IL118887A - Benzoylguanidines are converted to 4 fluoroalkyl, a process for their preparation and pharmaceutical preparations containing them - Google Patents

Benzoylguanidines are converted to 4 fluoroalkyl, a process for their preparation and pharmaceutical preparations containing them

Info

Publication number
IL118887A
IL118887A IL11888796A IL11888796A IL118887A IL 118887 A IL118887 A IL 118887A IL 11888796 A IL11888796 A IL 11888796A IL 11888796 A IL11888796 A IL 11888796A IL 118887 A IL118887 A IL 118887A
Authority
IL
Israel
Prior art keywords
carbon atoms
compound
alkyl
group
phenyl
Prior art date
Application number
IL11888796A
Other languages
English (en)
Hebrew (he)
Other versions
IL118887A0 (en
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL118887A0 publication Critical patent/IL118887A0/xx
Publication of IL118887A publication Critical patent/IL118887A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/45—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/52—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton the carbon skeleton being further substituted by doubly-bound oxygen atoms
    • C07C309/53—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton the carbon skeleton being further substituted by doubly-bound oxygen atoms the carbon skeleton containing carbon atoms of quinone rings
    • C07C309/54—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton the carbon skeleton being further substituted by doubly-bound oxygen atoms the carbon skeleton containing carbon atoms of quinone rings at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IL11888796A 1995-07-19 1996-07-18 Benzoylguanidines are converted to 4 fluoroalkyl, a process for their preparation and pharmaceutical preparations containing them IL118887A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19526381A DE19526381A1 (de) 1995-07-19 1995-07-19 4-Fluoralkyl-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Publications (2)

Publication Number Publication Date
IL118887A0 IL118887A0 (en) 1996-10-31
IL118887A true IL118887A (en) 2002-07-25

Family

ID=7767257

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11888796A IL118887A (en) 1995-07-19 1996-07-18 Benzoylguanidines are converted to 4 fluoroalkyl, a process for their preparation and pharmaceutical preparations containing them

Country Status (28)

Country Link
US (1) US6156800A (ru)
EP (1) EP0754680B1 (ru)
JP (1) JPH0931045A (ru)
KR (1) KR970006282A (ru)
CN (1) CN1072644C (ru)
AR (1) AR003461A1 (ru)
AT (1) ATE211463T1 (ru)
AU (1) AU704649B2 (ru)
BR (1) BR9603112A (ru)
CA (1) CA2181515A1 (ru)
CZ (1) CZ291240B6 (ru)
DE (2) DE19526381A1 (ru)
DK (1) DK0754680T3 (ru)
ES (1) ES2170183T3 (ru)
HR (1) HRP960343B1 (ru)
HU (1) HUP9601976A3 (ru)
IL (1) IL118887A (ru)
MX (1) MX9602841A (ru)
NO (1) NO306612B1 (ru)
NZ (1) NZ299015A (ru)
PL (1) PL183906B1 (ru)
PT (1) PT754680E (ru)
RU (1) RU2165412C2 (ru)
SI (1) SI0754680T1 (ru)
SK (1) SK281604B6 (ru)
TR (1) TR199600588A2 (ru)
TW (1) TW462960B (ru)
ZA (1) ZA966106B (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19526381A1 (de) * 1995-07-19 1997-01-23 Hoechst Ag 4-Fluoralkyl-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
CA2337087C (en) * 2000-03-08 2006-06-06 Canon Kabushiki Kaisha Magnetic toner, process for production thereof, and image forming method, apparatus and process cartridge using the toner
DE10222192A1 (de) * 2002-05-18 2003-11-27 Aventis Pharma Gmbh Pentafluorsulfuranyl-benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
US7375138B2 (en) * 2002-05-18 2008-05-20 Sanofi-Aventis Deutschland Gmbh Pentafluorosulfanylbenzoylguanidines, processes for their preparation, their use as medicaments or diagnostic aids, and medicaments comprising them
US20050124666A1 (en) * 2003-11-13 2005-06-09 Aventis Pharma Deutschland Gmbh Pentafluorosulfanylbenzoylguanidines, process for their preparation, use as a medicament or diagnostic aid, and medicament comprising same
OA13285A (en) * 2003-11-13 2007-01-31 Sanofi Aventis Deutschland Pentafluorosulfanyl benzoylguanidines, method for their production, their use as medicaments or diagnostic agents and medicament containing the same.
WO2021026402A1 (en) 2019-08-07 2021-02-11 Abbott Laboratories Chemiluminescent compounds for multiplexing

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3780027A (en) * 1970-04-29 1973-12-18 Merck & Co Inc Anthranilic acid derivatives
DE3929582A1 (de) * 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
DK0556674T3 (da) * 1992-02-15 1996-10-14 Hoechst Ag 3,5-Substituerede benzoylguanidiner med antiarytmisk virkning og inhiberende virkning på celleproliferation
ATE157351T1 (de) * 1993-02-20 1997-09-15 Hoechst Ag Substituierte benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament, als inhibitoren des zellulären na+/h+-austauschs oder als diagnostikum sowie sie enthaltendes medikament
DE4328869A1 (de) * 1993-08-27 1995-03-02 Hoechst Ag Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19526381A1 (de) * 1995-07-19 1997-01-23 Hoechst Ag 4-Fluoralkyl-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
NO962999L (no) 1997-01-20
JPH0931045A (ja) 1997-02-04
DE59608533D1 (de) 2002-02-07
AR003461A1 (es) 1998-08-05
SK93896A3 (en) 1997-05-07
ES2170183T3 (es) 2002-08-01
TW462960B (en) 2001-11-11
HUP9601976A3 (en) 1998-07-28
CN1072644C (zh) 2001-10-10
AU6056396A (en) 1997-01-23
PL314278A1 (en) 1997-01-20
HUP9601976A2 (en) 1997-09-29
PL183906B1 (pl) 2002-07-31
IL118887A0 (en) 1996-10-31
HRP960343A2 (en) 1998-02-28
BR9603112A (pt) 1998-05-05
MX9602841A (es) 1997-01-31
CZ212096A3 (en) 1997-04-16
EP0754680A1 (de) 1997-01-22
TR199600588A2 (tr) 1997-03-21
RU2165412C2 (ru) 2001-04-20
EP0754680B1 (de) 2002-01-02
US6156800A (en) 2000-12-05
SI0754680T1 (en) 2002-04-30
CZ291240B6 (cs) 2003-01-15
PT754680E (pt) 2002-06-28
HU9601976D0 (en) 1996-09-30
DE19526381A1 (de) 1997-01-23
SK281604B6 (sk) 2001-05-10
NO962999D0 (no) 1996-07-18
NZ299015A (en) 1997-08-22
HRP960343B1 (en) 2002-02-28
CA2181515A1 (en) 1997-01-20
CN1143076A (zh) 1997-02-19
DK0754680T3 (da) 2002-04-15
KR970006282A (ko) 1997-02-19
ATE211463T1 (de) 2002-01-15
AU704649B2 (en) 1999-04-29
NO306612B1 (no) 1999-11-29
ZA966106B (en) 1997-02-03

Similar Documents

Publication Publication Date Title
US5364868A (en) Amino-substituted benzoylguanidines, process for their preparation, their use as a medicament and medicament containing them
AU658262B2 (en) Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicaments containing them
US5373024A (en) 3,5-Substituted benzoylguanidines, process for their preparation, their use as a medicament of diagnostic and medicament containing them
US5965744A (en) Ortho-substituted benzoylguanidines, including composition and methods of using them
US5547953A (en) Substituted 1-oxo-1,2-dihydroisoquinolinoylguanidines and 1,1-dioxo-2H-1,2-benzothiazinoylguanidines, a process for their preparation, their use as medicaments or diagnostic agents, and medicaments containing them
IL106157A (en) Benzoyl guanidines 3,4,5-converted, method of preparation, use for the manufacture of a drug or diagnostic materials
US5516805A (en) 3,5-substituted aminobenzoylguanidines, their use as a medicament or diagnostic and medicament containing them
SK80395A3 (en) Guanidines of phenylsubstituted alkenylcarboxilic acid bearing perfluororalkyl groups, their preparation method, their use for drug preparation or diagnostic substance, as well as drug containing them
US5747541A (en) Substituted benzoylguanidines, a process for their preparation, their use as medicament of diagnostic agent, and medicament comprising them
CA2130031C (en) Urea-substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them
US6156800A (en) 4-fluoroalkyl-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
CA2152878A1 (en) Ortho-amino-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and also a medicament containing them
CA2206758C (en) Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
CZ231595A3 (en) Heterocycle-n-oxide substituted benzoylguanidines, process of their preparation, their use as a medicament or diagnostic agents, medicament containing said compounds and intermediates for their preparation
US5869531A (en) Fluoroalkyl substituted benzoylguanidines
US5756535A (en) Substituted thiophenylalkenylcarboxylic acid guanidines, processes for their preparation, their use as a medicament or diagnositc, and a medicament containing them
US6262123B1 (en) Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them
US5856574A (en) Ortho-subsituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
US6153651A (en) Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees